DiFUSE Technologies, based in Austin, Texas, received FDA clearance for the Xiphos line of posterior interbody devices for use during intervertebral body fusion of the lumbar spine from L2 to SI, according to a company news release.
The device is meant for skeletally mature patients who have had six months of non-operative treatment. It can be used at one level or two contiguous levels for degenerative disc disease with up to Grade I spondylolisthesis.
The implants can also be used to replace a vertebral body that has been resected or excised due to tumor or trauma fracture.
Read the DiFUSE release on the Xiphos line.
Read other coverage on spine devices:
- Medtronic Launches KYPHON Express Curette
- K2M Launches Lateral Access Spinal System
- Integra LifeSciences Receives FDA Clearance for ALIF Device
The device is meant for skeletally mature patients who have had six months of non-operative treatment. It can be used at one level or two contiguous levels for degenerative disc disease with up to Grade I spondylolisthesis.
The implants can also be used to replace a vertebral body that has been resected or excised due to tumor or trauma fracture.
Read the DiFUSE release on the Xiphos line.
Read other coverage on spine devices:
- Medtronic Launches KYPHON Express Curette
- K2M Launches Lateral Access Spinal System
- Integra LifeSciences Receives FDA Clearance for ALIF Device